loading

Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Costs And Expenses
19.68%
1.555
1.936 1.60 1.577 1.837
Depreciation and Amortization
-
- 0.003 0.002 0.012
Operating Income/Loss
19.68%
-1.555
-1.936 -1.60 -1.577 -1.837
Net Income/Loss
30.97%
-1.326
-1.921 -1.912 -1.532 -5.245
Basic Average Shares
0.00%
6.4062
6.4062 - 5.4358 5.087
Diluted Average Shares
0.00%
6.4062
6.4062 - 5.4358 5.087
Basic Earnings Per Share
30.00%
-0.21
-0.30 - -0.40 -1.03
Diluted Earnings Per Share
30.00%
-0.21
-0.30 - -0.40 -1.03
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Capitalizzazione:     |  Volume (24 ore):